Nurix Therapeutics Statistics

Total Valuation

NRIX has a market cap or net worth of $922.02 million. The enterprise value is $340.74 million.

Market Cap	922.02M
Enterprise Value	340.74M

Important Dates

The next estimated earnings date is Wednesday, April 9, 2025, before market open.

Earnings Date	Apr 9, 2025
Ex-Dividend Date	n/a

Share Statistics

NRIX has 75.89 million shares outstanding. The number of shares has increased by 23.52% in one year.

Current Share Class	75.89M
Shares Outstanding	75.89M
Shares Change (YoY)	+23.52%
Shares Change (QoQ)	+7.74%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	88.30%
Float	58.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.95
Forward PS	17.68
PB Ratio	1.75
P/TBV Ratio	1.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.46, with a Debt / Equity ratio of 0.05.

Current Ratio	6.46
Quick Ratio	6.38
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -53.22% and return on invested capital (ROIC) is -33.86%.

Return on Equity (ROE)	-53.22%
Return on Assets (ROA)	-25.98%
Return on Invested Capital (ROIC)	-33.86%
Return on Capital Employed (ROCE)	-37.15%
Revenue Per Employee	$190,731
Profits Per Employee	-$676,815
Employee Count	286
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

In the past 12 months, NRIX has paid $270,000 in taxes.

Income Tax	270,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.44% in the last 52 weeks. The beta is 2.18, so NRIX's price volatility has been higher than the market average.

Beta (5Y)	2.18
52-Week Price Change	-16.44%
50-Day Moving Average	16.38
200-Day Moving Average	20.76
Relative Strength Index (RSI)	30.68
Average Volume (20 Days)	921,936

Short Selling Information

The latest short interest is 12.17 million, so 16.04% of the outstanding shares have been sold short.

Short Interest	12.17M
Short Previous Month	11.60M
Short % of Shares Out	16.04%
Short % of Float	20.70%
Short Ratio (days to cover)	14.75

Income Statement

In the last 12 months, NRIX had revenue of $54.55 million and -$193.57 million in losses. Loss per share was -$2.88.

Revenue	54.55M
Gross Profit	-167.08M
Operating Income	-213.03M
Pretax Income	-164.82M
Net Income	-193.57M
EBITDA	-205.01M
EBIT	-213.03M
Loss Per Share	-$2.88

Full Income Statement

Balance Sheet

The company has $609.58 million in cash and $28.30 million in debt, giving a net cash position of $581.28 million or $7.66 per share.

Cash & Cash Equivalents	609.58M
Total Debt	28.30M
Net Cash	581.28M
Net Cash Per Share	$7.66
Equity (Book Value)	526.99M
Book Value Per Share	6.95
Working Capital	523.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$172.58 million and capital expenditures -$9.27 million, giving a free cash flow of -$181.86 million.

Operating Cash Flow	-172.58M
Capital Expenditures	-9.27M
Free Cash Flow	-181.86M
FCF Per Share	-$2.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-390.52%
Pretax Margin	-354.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRIX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.52%
Shareholder Yield	n/a
Earnings Yield	-20.99%
FCF Yield	-19.72%

Analyst Forecast

The average price target for NRIX is $30.82, which is 153.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.82
Price Target Difference	153.66%
Analyst Consensus	Strong Buy
Analyst Count	17
Revenue Growth Forecast (5Y)	51.24%
EPS Growth Forecast (5Y)	-40.79%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NRIX has an Altman Z-Score of 2.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.87
Piotroski F-Score	2